Differences in the mechanisms for relaxation of aorta induced by 17β-estradiol or progesterone between normotensive and hypertensive rats

European Journal of Pharmacology

Volumn 472, Issue 1-2, 2003, Pages 119-126

  Unemoto, Tamao ^a   Honda, Hideo ^a   Kogo, Hiroshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

17 Estradiol; Aorta; Endothelium; Inbred SHR, rat; K+ channel; Progesterone

Indexed keywords

4 AMINOPYRIDINE; ADENOSINE TRIPHOSPHATE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHANNEL; CALCIUM ION; ESTRADIOL; FULVESTRANT; GLIBENCLAMIDE; INDOMETACIN; METYRAPONE; MIFEPRISTONE; N(G) NITROARGININE; NORADRENALIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; PROGESTERONE; TETRYLAMMONIUM; VERAPAMIL;

ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DEPOLARIZATION; DRUG MECHANISM; HORMONE ACTION; HYPERTENSION; ISOLATED ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; TENSION; THORACIC AORTA; VASCULAR RING;

EID: 0038643835     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01858-2     Document Type: Article

References (35)

1. Adams M.R., Clarkson J.R., Kaplan J.R., Koritnik D.R. Ovarian secretions and atherosclerosis. Naftoli F., Gutmann J.N., Decherney A.H., Sarrel P.M. Ovarian Secretion and Cardiovascular and Neurological Function. 1990;151-159 Raven Press, New York, NY.
2. Adams M.R., Williams J.K., Kaplan J.R. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler. Thromb. Vasc. Biol. 15:1995;562-570.
3. Bauersachs J., Popp R., Hecker M., Sauer E., Fleming I., Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 94:1996;3341-3347.
4. Belfort M.A., Saade G.R., Suresh M., Vedernlkov Y.P. Effects of estradiol-17β and progesterone on isolated human omental artery from premenopausal nonpregnant women and from normotensive and preeclamptic pregnant women. Am. J. Obstet. Gynecol. 174:1996;246-253.
5. Bolton T.B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol. Rev. 59:1979;606-718.
6. Cambotti L.J., Cole F.E., Gerall A.A., Frohlich E.D., Macphee A.A. Neonatal gonadal hormones and blood pressure in the spontaneously hypertensive rat. Am. J. Physiol. 11:1984;58-264. (17β-estradiol).
7. Chan H.Y., Yao X., Tsang S.Y., Chan F.L., Lau C.W., Huang Y. Different role of endothelium/nitric oxide in 17β-estradiol- and progesterone-induced relaxation in rat arteries. Life Sci. 69:2001;1609-1617.
8. Clarkson T.B., Shively C.A., Morgan T.M., Koritnik D.R., Adams M.R., Kaplan J.R. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Obstet. Gynecol. 75:1990;217-222.
9. Ferreira S.H., Moncada S., Vane J.R. Indomethacin and aspirin abolished prostaglandin release from spleen. Nature. 231:1971;233-239.
10. Gerhard M., Ganz P. How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation. 92:1995;5-8.
11. Godsland I.F., Wynn V., Crook D., Miller N.E. Sex, lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am. Heart J. 114:1987;1467-1503.
12. Holland M., Langton P.D., Standen N.B., Boyle J.P. Effects of BKCa channel activator, NS1619, on rat cerebral artery smooth muscle. Br. J. Pharmacol. 117:1996;119-129.
13. Honda H., Sakai Y. The mode of action of ifenprodil tartrate in isolated canine cerebral and femoral arteries. Arch. Int. Pharmacodyn. 285:1987;211-225.
14. Honda H., Unemoto T., Kogo H. Different mechanisms of testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats. Hypertension. 34:1999;1232-1236.
15. Hughes G.S., Mathu R.S., Margolius H.S. Sex steroid hormones are altered in essential hypertension. J. Hypertens. 7:1989;181-187.
16. Ie Y., Fung A., Forster C. Role of gender and vascular endothelium in rat aorta response to 17β-estradiol. Can. J. Physiol. Pharm. 75:1997;1393-1397.
17. G-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur. J. Pharmacol. 176:1990;219-223.
18. Jiang C.W., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br. J. Pharmacol. 104:1991;1033-1037.
19. Jiang C.W., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur. J. Pharmacol. 211:1992;163-167.
20. Kakucs R., Varbiro S., Szekacs B., Nadasy G.L., Acs N., Monos E. Direct relaxing effect of estradiol-17β and progesterone on rat saphenous artery. Microvasc. Res. 56:1998;139-143.
21. Khaw K.T., Barret-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. J. Hypertens. 6:1988;329-332.
22. Kristof A.S., Noorhosseini H., Hussain S.N. Attenuation of endothelium-dependent hyperpolarizing factor by bacterial lipopolysaccharides. Eur. J. Pharmacol. 328:1997;69-73.
23. + current by chlorpromazine and 4-aminopyridine in neurons of the rat dorsal root ganglia. Br. J. Pharmacol. 109:1993;1239-1246.
24. Satake N., Shibata M., Shibata S. Endothelium- and cytochrome P-450-dependent relaxation induced by isoproterenol in rat aortic rings. Eur. J. Pharmacol. 319:1997;37-41.
25. ++ entry blockers on myosin light chain kinase and protein kinase C. Eur. J. Pharmacol. 163:1989;151-155.
26. Share L., Crofton J.T., Ouchi Y. Vasopressin: sexual dimorphism in secretion, cardiovascular actions and hypertension. Am. J. Med. Sci. 295:1988;314-319.
27. Stampfer M.J., Golditz G.A., Willett W.C., Manson J.E., Rosner B., Speizer F.E., Hennekens C.H. Postmenopausal estrogen therapy and cardiovascular disease. N. Engl. Med. 325:1991;756-762.
28. + channels in arterial smooth muscle. Science. 245:1989;177-180.
29. Sullivan J.M., Vander-Zwaag R., Lemp G.F., Hughes J.P., Maddock V., Kroetz F.W., Ramanathan K.B., Mirvis D.M. Postmenopausal estrogen use and coronary atherosclerosis. Ann. Intern. Med. 108:1988;358-363.
30. Tamura K., Honda H., Mimaki Y., Sashida Y., Kogo H. Inhibitory effect of a new steroidal saponin, OSW-1, on ovarian functions in rats. Br. J. Pharmacol. 121:1997;1796-1802.
31. Wild R.A., Bartholemew M.J. The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome. Am. J. Obstet. Gynecol. 159:1988;423-427.
32. Wilson J.D. Hormones and hormone antagonists. Hardman J.G., Goodman Gilman A., Lee E.L. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. 1996;1443 McGraw-Hill, Health Professions Division, New York, NY.
33. + channel opener cromakalim in canine coronary artery. Jpn. J. Pharmacol. 59:1992;291-299.
34. Yamaguchi K., Honda H., Tamura K., Kogo H. Possible mechanisms for the suppressing action of 17β-estradiol on β-adrenoceptor-mediated vasorelaxation in rat aorta. Eur. J. Pharmacol. 427:2001;61-67.
35. Yue R.Y., Chatterjee K., Beale C., Wilson A.P., Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 91:1995;1154-1160.